Literature DB >> 21515361

Evidence demonstrating role of microRNAs in the etiopathology of major depression.

Yogesh Dwivedi1.   

Abstract

Major depression is a debilitating disease. Despite a tremendous amount of research, the molecular mechanisms associated with the etiopathology of major depression are not clearly understood. Several lines of evidence indicate that depression is associated with altered neuronal and structural plasticity and neurogenesis. MicroRNAs are a newly discovered prominent class of gene expression regulators that have critical roles in neural development, are needed for survival and optimal health of postmitotic neurons, and regulate synaptic functions, particularly by regulating protein synthesis in dendritic spines. In addition, microRNAs (miRNAs) regulate both embryonic and adult neurogenesis. Given that miRNAs are involved in neural plasticity and neurogenesis, the concept that miRNAs may play an important role in psychiatric illnesses, including major depression, is rapidly advancing. Emerging evidence demonstrates that the expression of miRNAs is altered during stress, in the brain of behaviorally depressed animals, and in human postmortem brain of depressed subjects. In this review article, the possibility that dysregulation of miRNAs and/or altered miRNA response may contribute to the etiology and pathophysiology of depressive disorder is discussed.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21515361      PMCID: PMC3163781          DOI: 10.1016/j.jchemneu.2011.04.002

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  184 in total

1.  MicroRNA expression in rat brain exposed to repeated inescapable shock: differential alterations in learned helplessness vs. non-learned helplessness.

Authors:  Neil R Smalheiser; Giovanni Lugli; Hooriyah S Rizavi; Hui Zhang; Vetle I Torvik; Ghanshyam N Pandey; John M Davis; Yogesh Dwivedi
Journal:  Int J Neuropsychopharmacol       Date:  2011-01-28       Impact factor: 5.176

Review 2.  Non-coding RNAs: hope or hype?

Authors:  Alexander Hüttenhofer; Peter Schattner; Norbert Polacek
Journal:  Trends Genet       Date:  2005-05       Impact factor: 11.639

Review 3.  Non-coding RNAs: regulators of disease.

Authors:  Ryan J Taft; Ken C Pang; Timothy R Mercer; Marcel Dinger; John S Mattick
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

Review 4.  Differential translation and fragile X syndrome.

Authors:  P W Vanderklish; G M Edelman
Journal:  Genes Brain Behav       Date:  2005-08       Impact factor: 3.449

5.  Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings.

Authors:  G Rosoklija; G Toomayan; S P Ellis; J Keilp; J J Mann; N Latov; A P Hays; A J Dwork
Journal:  Arch Gen Psychiatry       Date:  2000-04

6.  A novel microRNA and transcription factor mediated regulatory network in schizophrenia.

Authors:  An-Yuan Guo; Jingchun Sun; Peilin Jia; Zhongming Zhao
Journal:  BMC Syst Biol       Date:  2010-02-15

7.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

Authors:  M A Smith; S Makino; R Kvetnansky; R M Post
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

Review 8.  Gliogenesis and glial pathology in depression.

Authors:  G Rajkowska; J J Miguel-Hidalgo
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-06       Impact factor: 4.388

9.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

10.  Changes in brain MicroRNAs contribute to cholinergic stress reactions.

Authors:  Ari Meerson; Luisa Cacheaux; Ki Ann Goosens; Robert M Sapolsky; Hermona Soreq; Daniela Kaufer
Journal:  J Mol Neurosci       Date:  2009-08-27       Impact factor: 3.444

View more
  49 in total

Review 1.  Pathogenetic and therapeutic applications of microRNAs in major depressive disorder.

Authors:  Yogesh Dwivedi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-02-14       Impact factor: 5.067

2.  microRNAs as Biomarker in Depression Pathogenesis.

Authors:  Yogesh Dwivedi
Journal:  Ann Psychiatry Ment Health       Date:  2013-12-02

3.  Evaluation of Selected MicroRNAs Expression in Remission Phase of Multiple Sclerosis and Their Potential Link to Cognition, Depression, and Disability.

Authors:  Marta Niwald; Monika Migdalska-Sęk; Ewa Brzeziańska-Lasota; Elżbieta Miller
Journal:  J Mol Neurosci       Date:  2017-10-17       Impact factor: 3.444

Review 4.  Understanding epigenetic architecture of suicide neurobiology: A critical perspective.

Authors:  Bhaskar Roy; Yogesh Dwivedi
Journal:  Neurosci Biobehav Rev       Date:  2016-11-09       Impact factor: 8.989

Review 5.  The involvement of microRNAs in major depression, suicidal behavior, and related disorders: a focus on miR-185 and miR-491-3p.

Authors:  Gianluca Serafini; Maurizio Pompili; Katelin F Hansen; Karl Obrietan; Yogesh Dwivedi; Noam Shomron; Paolo Girardi
Journal:  Cell Mol Neurobiol       Date:  2013-11-09       Impact factor: 5.046

Review 6.  MicroRNAs in depression and suicide: Recent insights and future perspectives.

Authors:  Yogesh Dwivedi
Journal:  J Affect Disord       Date:  2018-07-24       Impact factor: 4.839

7.  MicroRNAs 29b and 181a down-regulate the expression of the norepinephrine transporter and glucocorticoid receptors in PC12 cells.

Authors:  Maoxian Deng; Turan Tufan; Muhammad U Raza; Thomas C Jones; Meng-Yang Zhu
Journal:  J Neurochem       Date:  2016-09-22       Impact factor: 5.372

8.  7-Chlorokynurenic acid (7-CTKA) produces rapid antidepressant-like effects: through regulating hippocampal microRNA expressions involved in TrkB-ERK/Akt signaling pathways in mice exposed to chronic unpredictable mild stress.

Authors:  Bin-Bin Liu; Liu Luo; Xiao-Long Liu; Di Geng; Qing Liu; Li-Tao Yi
Journal:  Psychopharmacology (Berl)       Date:  2014-07-18       Impact factor: 4.530

9.  Coordinated messenger RNA/microRNA changes in fibroblasts of patients with major depression.

Authors:  Krassimira A Garbett; Andrea Vereczkei; Sára Kálmán; Jacquelyn A Brown; Warren D Taylor; Gábor Faludi; Željka Korade; Richard C Shelton; Károly Mirnics
Journal:  Biol Psychiatry       Date:  2014-06-02       Impact factor: 13.382

Review 10.  A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates.

Authors:  Sarel J Brand; Marisa Moller; Brian H Harvey
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.